We aim to study the clinical, hormonal, and molecular characterization in patients with atypical congenital adrenal hyperplasia (CAH). This study includes congenital lipoid adrenal hyperplasia, 3?-hydroxysteroid dehydrogenase deficiency, 11?-hydroxylase deficiency, 17?-hydroxylase deficiency, and P450 oxidoreductase deficiency.
